| Non-cell-autonomous cancer progression from chromosomal instability J Li, MJ Hubisz, EM Earlie, MA Duran, C Hong, AA Varela, E Lettera, ... Nature 620 (7976), 1080-1088, 2023 | 93 | 2023 |
| Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model Y Philippou, HT Sjoberg, E Murphy, S Alyacoubi, KI Jones, ... British journal of cancer 123 (7), 1089-1100, 2020 | 73 | 2020 |
| The clinical and molecular significance associated with STING signaling in breast cancer EE Parkes, MP Humphries, E Gilmore, FA Sidi, V Bingham, SM Phyu, ... NPJ Breast Cancer 7 (1), 81, 2021 | 30 | 2021 |
| Effects of administered cardioprotective drugs on treatment response of breast cancer cells TAD Smith, SM Phyu, EU Akabuogu Anticancer Research 36 (1), 87-93, 2016 | 29 | 2016 |
| Metformin decouples phospholipid metabolism in breast cancer cells TAD Smith, SM Phyu PLoS One 11 (3), e0151179, 2016 | 21 | 2016 |
| Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy: routes to glycogen synthase kinase 3 SM Phyu, CC Tseng, IN Fleming, TAD Smith Scientific Reports 6 (1), 36544, 2016 | 17 | 2016 |
| Changes in [18F]Fluoro-2-deoxy-d-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with … AC Cooper, IN Fleming, SM Phyu, TAD Smith Journal of cancer research and clinical oncology 141, 1523-1532, 2015 | 17 | 2015 |
| Combination treatment of cancer cells with pan-Akt and pan-mTOR inhibitors: effects on cell cycle distribution, p-Akt expression level and radiolabelled-choline incorporation SM Phyu, TAD Smith Investigational new drugs 37, 424-430, 2019 | 10 | 2019 |
| CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor SM Phyu, CC Tseng, TAD Smith Magnetic Resonance Materials in Physics, Biology and Medicine 32, 227-235, 2019 | 9 | 2019 |
| Response detection of castrate‐resistant prostate cancer to clinically utilised and novel treatments by monitoring phospholipid metabolism TAD Smith, SM Phyu, KS Alzyoud, CC Tseng BioMed Research International 2017 (1), 4793465, 2017 | 3 | 2017 |
| Determination of Rate of [3H-methyl]-choline Incorporation into Cellular Lipids and Non-lipid Metabolites TAD Smith, SM Phyu Bio-protocol 6 (22), e2019-e2019, 2016 | 2 | 2016 |
| The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer EE Parkes, MP Humphries, E Gilmore, FA Sidi, V Bingham, SM Phyu, ... bioRxiv, 2020.07. 23.217398, 2020 | 1 | 2020 |
| Investigating the STING pathway in the prostate cancer tumour immune microenvironment and radiosensitivity CY Chan, J Kwon, EA Murphy, SM Phyu, K Shigemori, IG Mills, RJ Bryant, ... European Urology 85, S2205, 2024 | | 2024 |
| IGFs regulate cancer cell immune evasion in prostate cancer AM Nandakumar, A Barberis, J Kim, CR Lang, JV Mills, G Rieunier, ... bioRxiv, 2024.12. 03.626600, 2024 | | 2024 |
| Investigating the effects of homologous recombination deficiency on radiotherapy response in pre-clinical prostate cancer J Kwon, EA Murphy, C Chan, S Afolaranmi, SM Phyu, RJ Bryant, ... European Urology 83, S1664, 2023 | | 2023 |
| Chromosomal instability shapes the tumor microenvironment through a chronic ER-stress response J Li, M Hubisz, E Earlie, MA Duran, E Lettera, SM Phyu, AD Amin, ... Cancer Research 82 (12_Supplement), 3822-3822, 2022 | | 2022 |
| Targeting of the PI3K/AKT/mTOR signalling pathway and associated kinases in breast and colon cancer cells and response evaluation by molecular imaging techniques SM Phyu University of Aberdeen, 2018 | | 2018 |
| Research Article Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism TAD Smith, SM Phyu, KS Alzyoud, CC Tseng | | 2017 |
